Showing posts with label canadian pharmacy. Show all posts
Showing posts with label canadian pharmacy. Show all posts

Wednesday, October 5, 2016

The fighting cancer by making changes to her lifestyle and eating healthy


A small swelling constantly reminds Radhika Singh of what is she up against — breast cancer. But the 51-year-old isn't on medication; she's trying to fight cancer by making changes to her lifestyle and eating healthy.

"There's no guarantee that the cancer won't come back after chemotherapy so I didn't want to go through it and deal with the side effects," says Singh, who moved from Delhi to Mashobra in Himachal Pradesh to be in a cleaner environment. Since 2010 when she got her cancerous lump removed, she's been on a strict diet of organic fruit and vegetables, which she grows herself, and avoids dairy and gluten (wheat and wheat products).

While Singh might have taken a drastic route by saying no to chemo, for other survivors, a cancer diagnosis offers a bittersweet opportunity to make lifestyle changes that may ultimately save their lives. The changes are simple: cut the crap (no smoking, drinking, processed food and sugars), exercise, and eat food that's free of chemical fertilizers, pesticides and growth hormones.

There's no clear scientific evidence to show that lifestyle and diet can cure cancer, but patients point out that there are no guarantees in life — all one can do is maximize your chances with healthy habits.

Amit Vaidya came to India from the US in 2012 after doctors told him that he didn't have long to live as his gastric cancer had returned after being in remission since 2009. He had undergone 70 rounds of chemo, and radiation therapy. "My decision to come to India was to get palliative care. As part of that plan, I changed my lifestyle and diet, and underwent cow therapy. To my surprise, I started getting better and stronger," he says.

He documented his experiences in the book 'Holy Cancer: How a cow saved my life'. Vaidya wakes up at 4.30am every day, meditates and does yoga, and walks 10km. He chews raw tulsi and neem leaves, and drinks a glass of warm water with organic honey before breakfast. He says it is very important to know where his food is coming from, and he lives close to the source of the food. "I only consume ghee and milk of desi cows, which have not been fed on a diet of hormones," says Vaidya, 38, who lives on Vypeen, an island off Kochi in Kerala. He says the lifestyle changes are life-long and cannot be abandoned if cancer goes into remission. Delhi-based nutritionist Ishi Khosla says people with cancer often seek her help to manage their symptoms with diet. While it doesn't work in every case, Khosla says "most people do feel some difference".

Anjali Sapra, an artist based in Delhi, says eating right can make a difference even while undergoing chemo. Diagnosed with breast cancer in 2014, Sapra underwent surgery and chemo, which left her sense of taste and smell compromised, thus affecting her appetite. "It's important to eat well during chemo as it boosts your immunity. But most patients are unable to because of the side-effects of chemo. Even, carers, often, don't know what to cook for the patient," explains Sapra. Dr Ramesh Sarin, senior oncologist at Apollo Hospitals in Delhi, says there's no well-controlled study to support any diet that prevents cancer. "While some studies indicate sugar is bad for cancer, there's no solid study to say cut sugar completely from the diet. Similarly, we know that some insecticides have been shown to cause cancer but not all. So while eating organic is good, we cannot say eating non-organic food is bad," says Dr Sarin. Overall, oncologists encourage patients to cut down on refined sugar, consume fruit and vegetables, and avoid red meat.

Mumbai's The Health Awareness Centre (THAC), an institution that promotes healthy eating and living, sees about five people with cancer every day. Started by nutritionist Dr Vijaya Venkta, THAC recently conducted a small study in collaboration with Tata Memorial Hospital on the effect of diet and lifestyle on managing cancer.

During the study, five palliative cancer patients in Bhakti Vedanta Hospital (Mira Road), were exposed to a corrective diet and corrected exposure to sunlight for 14 days. At the end of the period, four patients reported no symptoms, one had reduced symptoms and all were on reduced dosage of morphine. "We have seen patients benefiting from such changes. In some cases, tumours have reduced, in some the size has remained the same...how much each person improves is different. But, clearly, food seems to the pharmacy now," says Anju Venkat, nutritionist at THAC.


http://timesofindia.indiatimes.com/home/sunday-times/Fighting-cancer-with-common-sense/articleshow/54633285.cms

Monday, September 12, 2016

Karnataka government is all set to provide a boost to the pharma sector in the state


Karnataka government is all set to provide a boost to the pharma sector in the state with cabinet approving a dedicated Pharmaceutical Policy. The Pharmaceutical Policy will become part of state's Industrial Policy as a separate chapter. The specific benefits extended to pharma sector are in addition to benefits under state's Industrial Policy. The government has now devised a three pronged approach to spur sustained growth in drug research, development and manufacturing space. It has now mooted creation of an incubation centre, financial assistance to students in Finishing Schools and incentives to industry to capture new opportunities.

The first initiative in this regard is by way of setting up an incubation centre within the 71 pharmacy colleges in the state. The government has consented to provide Rs. 2 crore to each of the colleges which have the infrastructure and personnel to man an incubators. The most likely takers for a start would be the Acharya & B M Reddy College of Pharmacy in Bengaluru, Manipal College of Pharmaceutical Sciences and JSS Pharmacy College of Pharmacy in Mysuru, according to officials familiar with the development.

There is a huge demand for incubators and with the Start-up India Policy, the focus is on innovation, fostering sustainable and scalable ventures. There are incubators established within the campuses of the Indian Institute of Science, Centre for Cellular and Molecular Platform (C-CAMP) in the GKVK campus besides the Jawaharlal Centre for Advanced Research in Bengaluru which are largely dominated by biotech and med-tech entrepreneurs.

“But specific for the pharma industry, there is a need for a stand-alone incubator. The 71 pharmacy colleges generate around 11,000 pharmacy graduates annually and there is a perceptible interest for incubators to ignite the innovation spark, Harish K Jain, secretary, KDPMA and director, Embiotic Laboratories told Pharmabiz.

With a strategy to provide the pharma sector with industry ready candidates, the state government in principle has agreed to subsidize the fees to students in Finishing Schools to an extent of Rs. 10,000 per candidate. The current fees is about Rs. 20,000 and this will benefit existing institutes like the Pharmacy Training Institute in Bengaluru.

Particularly for the industry, the government will offer financial grants which is over and above the existing central government support. Further, the formation of a Vision Group for Pharmaceuticals is also underway.

The state pharma industry accounts for a total turnover of Rs. 12,000 crore of which exports accounts for Rs. 5,000 crore. The state exchequer receives around Rs. 500 crore from the pharma sector. These development initiatives together with the state’s access to talent pool would surely create a spurt in growth, noted Jain.


http://pharmabiz.com/ArticleDetails.aspx?aid=97317&sid=1

Thursday, September 8, 2016

The Economic Times that said Zigy owned by PM Health & Life Care pharmacy Zigy scales down operations

Zigy, an online pharmacy startup founded by former Infosys director and IGATE CEO Phaneesh Murthy, is scaling back its operations due to a paucity of funds but has no plans to shut down, a top executive said.

“We are not shutting down,” Zigy CEO Hemant Bhardwaj told TechCircle. He was denying a report in The Economic Times that said Zigy, owned by PM Health & Life Care Pvt. Ltd, might halt operations within three months as it had been unable to raise funds.

Bhardwaj said the company is “strengthening” itself in Bengaluru, where it will be operational for retail customers. “For institutional customers, we are operational in all five cities (Bengaluru, Chennai, Hyderabad, Mumbai and Delhi),” he said. The company earlier catered to retail customers in all five cities.

Bhardwaj also denied that the company was looking for a merger to exit the business. “There is no merger situation at this point in time. We would like Zigy to thrive on its own. Seven to 10 months is too early to decide to merge a company. We will keep all opportunities on the table and keep exploring,” he said.

The Economic Times, which cited three people aware of the development it didn’t name, also said that regulatory restrictions had hampered the company’s growth.

Zigy.com, a marketplace that connects chemists with consumers, was launched in August 2015 by Murthy as part of a health exchange platform that also included Zigy Health Vault, a patient-controlled health record system. Murthy, who was sacked from IGATE over sexual harassment charges, was reportedly looking to raise $10-12 million for Zigy.

Online drug startups have been facing regulatory hurdles as the Drug Controller General of India has put a restriction on the sale of medicines online. However, startups in this segment claim that the regulator’s warning has not affected their business.

A number of brick-and-mortar chemists such as MedPlus and Guardian Lifecare, too, have ventured into the online segment. Bengaluru-based Practo, an appointment booking platform for patients and doctors, has also begun online delivery of medicines.


http://techcircle.vccircle.com/2016/09/07/online-pharmacy-zigy-may-shut-operations-in-three-months/

Friday, August 12, 2016

The Cambridgeshire and Peterborough Clinical Commissioning Group medication pharmacies need to GP

The Cambridgeshire and Peterborough Clinical Commissioning Group say patients will no longer be able to reorder their medication through their pharmacy.

A spokesman said: “They will need in future to request these through their GP. This will ensure that patients only receive the medication they need.”

The spokesman said this would mean the medication can be reviewed and would hopefully reduce the amount of wasted medicines.

“On average £7.5 million of medicines are wasted each year across Cambridgeshire and Peterborough,” said the spokesman.

“Previously patients could sign up to a managed repeat prescription service with their pharmacy where the pharmacy would automatically request medication on the patient’s behalf.”

It is expected the new service will be rolled out to 50 practices a year.

“This will not impact on vulnerable patients where alternative arrangements are in place, “said the spokesman.

http://www.wisbechstandard.co.uk/news/health_chiefs_to_stop_cambridgeshire_patients_getting_repeat_prescriptions_from_pharmacies_in_future_you_will_need_to_see_gp_1_4653708

Monday, August 8, 2016

The Pharmacy Guild of New Zealand congratulates Community Pharmacy of the Year 547

Guild congratulates Community Pharmacy of the Year, Pharmacy 547

The Pharmacy Guild of New Zealand (the Guild) congratulates Pharmacy 547 for winning the Community Pharmacy of the Year award at the 2016 Pharmacy Awards held on Saturday night (6 August).

This year’s awards ceremony was held at the Pullman Hotel in Auckland and saw approximately 370 pharmacy stakeholders from around the country attend the event.

Guild Chief Executive, Andrew Gaudin says “The Guild was extremely honoured to co-host the 2016 Pharmacy Awards for the second time, alongside Pharmacy Today. At the Guild we aspire to see the highest quality of care delivered to patients through community pharmacy in New Zealand and it is a privilege to be so closely involved with an event that celebrates this work.”

“The Guild was proud to again sponsor the Community Pharmacy of the Year award. This year the prestigious award went to Guild member pharmacy, Pharmacy 547, who is thoroughly deserving of this recognition and a prime example of what our patients’ value about community pharmacy.

“The runner up in this category was Guild member pharmacy, Sanders Pharmacy, whose team is also providing an outstanding service to their community. The judges visited finalist pharmacies to see them in action and Pharmacy 547 was judged as the winner. Christchurch pharmacies, Crisps Healthy Living Pharmacy and St Martins Pharmacy, were also judged as highly commended. We are extremely grateful to all pharmacies who took the time to enter this award category and share the excellent work they are doing for the benefit of their patients.

“Pharmacy 547 is located in Hamilton and is led by Ian McMichael. The pharmacy has a philosophy that it needs to be constantly re-inventing itself and adapting what they do in a constantly changing and challenging world.

“In the last year they settled into new premises and made the most of the purpose-built facilities.

Pharmacy 547 believes in three A’s: How can we make health care accessible, affordable and accurate for the people who access our pharmacy services?

“The judges said that all finalists in this category showed a clear understanding of their patients’ needs and that they were delivering services to meet these needs in their local communities. They commented that all had a commitment to patient focused services that were innovative and allowed the pharmacists to work at the top of their scope for the benefit of their community.

“The high calibre of entries was consistent across all award categories with the judges commenting that selecting winners was no easy task.

“The Guild endeavours to support community pharmacy by freeing up time for owners to concentrate on what they do best – providing fantastic services into their community. At the awards we acknowledged a range of outstanding services, and it is our desire to see these services being embedded throughout the pharmacy sector in everyday practice.”

Our congratulations go out to all 2016 finalists and winners who are:

Pharmacy Guild Community Pharmacy of the Year

Winner: Ian McMichael, Alice Madsen, Alexis Mirkin, Pharmacy 547

Runner-up: Gemma Waterhouse-Perry, Sanders Pharmacy

Blackmores Future Pharmacist of the Year

Winner: Sophie Oliff, University of Otago

Runner-up: Kate Farmer, University of Auckland

Douglas Young Pharmacist of the Year

Winner: Charles Walker, Merrilands Pharmacy

Runner-up: Nafessa Mussa, Leanna Peachey and Truc Nguyen, Middlemore Hospital Pharmacy

GlaxoSmithKline "Good Sort" Pharmacist of the Year

Winner: Mark Webster, Stay Well Pharmacy

Runner-up: Mike Riordan, Unichem Mainstreet Pharmacy

Innovation in Delivering Care and Advice

Winner: Mark Webster, Stay Well Pharmacy

Runner-up: Samit Patel, Unichem Greenhithe Pharmacy

Aspen Pharmacare + Pamol Self Care Award

Winner: Amy Chan, Kiri Aikman, Ziyen Lam, Natasha Pool, Ricky Wan, Sarah Wang, Joe Monkhouse,

Auckland DHB Inpatient Pharmacy

The Pharmaceutical Society of New Zealand Professional Service of the Year

Winner: Eui-Jin Kim and Michael Hammond, Rotorua Area Primary Health Services

Runner-up: Cath Knapton, Midland Community Pharmacy Group

ProPharma Technician Superstar(s)

Winner: Dianne Gulliver, Sian Dawson, and Kim Brackley, Pharmacy Department Auckland DHB

Runner-up: Sandra Edmondson, Pharmacy Department Christchurch Hospital

Voltaren Retail Superstar(s)

Winner: Clair Connor and Glenys Perry, Life Pharmacy Botany

Runner-up: Lisa Erdman, Unichem Spitfire Square Pharmacy

Vitaco NutraLife Best Complementary Healthcare Campaign

Winner: Clair Connor, Life Pharmacy Botany

Runner-up: Mark Webster, Stay Well Pharmacy

PRISM Te Hapai Hauora Award

Winner: Leanne Te Karu, Nga Kāitiaki o Te Puna Rongoā o Aotearoa - The Māori Pharmacists' Association

Runner-up: Teei Kaiaruna, Pharmacy 547 and Samuel Martin, Huntly West Pharmacy

Onelink Hospital Pharmacy Performer of the Year

Winner: David Ryan, North Shore Hospital Inpatient Pharmacy

Runner-up: Hayley Velden, Michelle Murphy, Ryan Moxham-Smith, Hauora Tairawhiti Pharmacy

Department Gisborne Hospital

PSL Supplier Of The Year

Winner: Annette Smith, Pharmacy Wholesalers Russells and Noel Wright, ProPharma

Runner-up: Mike Siermans and Regan Cooper, Douglas Pharmaceuticals

RB Supreme Winner

Winner: Leanne Te Karu, Nga Kāitiaki o Te Puna Rongoā o Aotearoa - The Māori Pharmacists' Association

Runner-up: Ian McMichael, Alice Madsen, Alexis Mirkin, Pharmacy 547

http://www.scoop.co.nz/stories/BU1608/S00230/guild-congratulates-community-pharmacy-of-the-year.htm

Wednesday, July 27, 2016

Pharmacy will have to evolve as technologies are introduced and the Society of Hospital Pharmacists of Australia

Michaels was addressing the two day Future Summit, now being held in Melbourne.

Michaels says one of the most important issues being addressed is planning for an increasingly digitised healthcare system.

“We expect the role of the pharmacy workforce to evolve and this will accelerate with the introduction of electronic medication management systems and electronic medical records,” she says.

“These technological changes will have the attention of federal and state governments because of the potential impact on health budgets and because they will be keen to maximise advances in health outcomes.

“New electronic systems could pave the way for pharmacists and pharmacy technicians to have more time for bedside consultations, with other health professionals, and to ensure the best decisions are made about patient medication.”

Michaels says that SHPA is planning ahead to ensure the pharmacy workforce can take full advantage of likely changes to a digital healthcare system. This means ensuring SHPA provides the best support and continuing professional development, she says,

“One stream of Summit activity has been focused on the development of a tool kit for writing business cases. It will be used by pharmacists to support creation of new pharmacy services by undertaking analysis and presenting well-structured business cases to support their proposals.

“When pharmacists working in hospitals are keen to foster new initiatives to deliver better medications management, they are competing for limited funds against robust competition.

“Development of a well-considered, rigorous business case is an essential part of gaining appropriate funding in a competitive environment,” Michaels says.

“We are giving hospital pharmacists the tools and insights they need to design and follow through on medicines related initiatives that will elevate the quality and safety of health care in Australia’s hospitals.

“The Summit is also developing a mentoring program for pharmacists who are preparing for transition into more senior roles where they will require significant non-clinical skills.

“These skills could include leadership, management, communication, research and education,”  Michaels says.

“Participation in the Future Summit is very competitive and brings together pharmacy’s most important leaders and thought champions from around Australia. Participants are chosen via a rigorous selection process and they are working together to build robust foundations for future change.”

https://ajp.com.au/news/pharmacy-workforce-evolve/

The need to amend the Drugs and Cosmetics Act, 1940 to promote e-pharmacy in India

With the advent of e-pharmacy, there is a need to amend the Drugs and Cosmetics Act, 1940 as it does not differentiate between offline and online pharmacies. The government is seized of the issue and is working towards amending the existing law to develop a framework where the consumers are benefited, said K. B. Aggarwal, Additional Secretary (Food and Drugs), Ministry of Health & Family Welfare. He was launching a report at a session on 'E-pharmacy in India - Last Mile Access of Medicines' organised by FICCI.

Aggarwal said that e-pharmacy would allow easy availability of drugs at all hours. However, there were concerns with respect to legitimacy of e-pharmacies, patients safety and privacy, misuse of e-pharmacy and adverse effect on retailers business.

He said that there was a need to create e-pharmacy guidelines which allow proper tracking and monitoring of sales of drugs, authenticity of online pharmacists and prescriptions, details of patients, thereby helping in reducing drug abuse and counterfeiting. He added that linking a person's Aadhar number with e-pharmacy would ensure correctness of person seeking medicines.

Aggarwal said that for ensuring privacy and confidentiality of information, deliberations were taking place and soon the suggestions will be put up for further discussions among the stakeholders. He added that the DCGI was working towards developing its online platform and the system should be stable by the end of December 2016.

Dr. S. Eswara Reddy, Joint Drugs Controller, Central Drugs Standard Control Organization, said that the government was working towards drafting a new Drugs & Cosmetics Act, 2016 to meet the current regulatory requirements related to safety, efficacy and quality of drugs. For the government, pharmaceuticals was a priority sector, therefore it was critical to ensure that its regulations are strengthened. He added that there should be a standard format of prescriptions.

In his presentation Jayant Singh, Director, Frost & Sullivan, said that e-pharmacy was one of the technology advancements that is about to create a huge demand in the upcoming days. There was a huge demand for access models that help patients and consumers avail the convenience of medicine delivery without having to leave their homes. With the use of technology and access to inventory of multiple stores at a time, e-pharmacies can aggregate supplies, making otherwise-hard-to-find medicines available to consumers across the country.

Dr. Manisha Shridhar, Regional Adviser, World Health Organization, said that for sale of online drugs, in the EU legitimate online pharmacies will have to carry a logo and India could learn from their processes and create its own logo for e-pharmacy. She added that there was a need to work on Direct to Consumer (DTC) as with emergence of e-pharmacy many issues will emerge that would need to be deliberated upon.

In his presentation on the consumer survey, Afaq Hussain, Director, BRIEF Market Research, said that 90 per cent of the respondents were willing to buy medicines online as e-pharmacy brings with the convenience of ordering from mobile applications; all required medicines are available at one store/website; home delivery of medicines; better quality of medicines; better pricing and e-bill for tacking and reimbursement.

In his special address,  Arvind Gupta, Founder & Head, Digital India Foundation, said that there was a need to look at e-pharmacy sector in a comprehensive manner keeping in view the entire healthcare chain. He added that the Aadhar number should be integrated when a person seeks drugs from e-pharmacy to monitor drug abuse and its misuse. He added that there was a need to standardize labs to create digi lockers where the patients' records are safely documented for reference by doctors.

Prashant Tandon, Founder & CEO, 1MG, Core Member, FICCI E-Commerce Committee, said that digital tracking and monitoring will take Digital India forward. The Drugs and Cosmetics Act does not address many concerns, hence incremental steps were required to ensure access to quality medicines at affordable price. He added that e-pharmacy sector needs guidelines to function smoothly.

Dr. A Didar Singh, Secretary General, FICCI, said that there was an urgent need to nurture the e-pharmacy sector with the right set of policy frameworks and guidelines in order to provide the benefits that the sector fosters for the consumers. As one of the key agenda of the Government has been to provide easy, quality and affordable access of health services to the consumers, the evolving concept of e-pharmacy will definitely give an impetus to the health sector of the country.

http://www.pharmabiz.com/NewsDetails.aspx?aid=96491&sid=2

Sunday, July 10, 2016

chemists and online e-pharmacies to reach courts








NEW DELHI: The fight between brick-and mortar chemists and online pharmacies is set to reach courts now. The All India Organisation of Chemists and Druggists (AIOCD) will approach ten High Courts in India against the central and state drug regulators for lack of action against the "illegal" operation of online pharmacies, which could compromise patient safety.

On their part, online pharmacies are gearing up for the fight in the hopes that it would clarify misconceptions about process they follow and also "expose" public safety hazards offline pharmacies pose.

The move comes even while a health ministry sub-committee is evaluating online pharmacies and their impact on health. Online pharmacies are illegal in India and the central and state drug regulators' negligence in this matter risks public health, AIOCD general secretary Suresh Gupta told ET.



The current Drugs & Cosmetics Act (1940) does not allow online portals to sell medicines, he said. "A major problem (with online pharmacies) is that the medicine could maybe change in transit.


It could be spurious and threaten the health of the (patient)," said Gupta. "It is surprising that the government is not taking action even when there is no law at present that allows online sale of medicines.


We are moving High Courts in at least 10 states." AIOCD's state-level units are in the process of preparing petitions against the government and will soon approach the High Courts in states like Delhi, Maharashtra, Uttar Pradesh, Tamil Nadu and Andhra Pradesh, said Gupta.

http://timesofindia.indiatimes.com/tech/tech-news/Chemists-to-take-e-pharmacies-to-court/articleshow/53131252.cms

Saturday, July 9, 2016

Pharma units face water, power supply problems:Pharmaceutical Manufacturers Association (GPMA)








Water, uninterrupted power supply and availability of skilled manpower are the major concerns affecting the working of pharmaceutical companies, highlighted the Goa Pharmaceutical Manufacturers Association (GPMA) recently.

The GPMA has asked to the government to take up the issues with various departments to help the industry. It also urged the EDC to come up with some incentives or schemes for upgradation of manufacturing units to meet ever growing requirements of regulatory guidelines.

The GPMA is also appealed to state FDA and the Central Drugs Standard Control Organisation (CDSCO), Goa to take up consultative meetings for updation of Drugs and Cosmetics Act 1945 to meet current scenario of export requirements.

The demands were made at the GPMA annual general meeting wherein Francis D’Souza, deputy chief minsiter was the chief guest. Speaking on the occasion D’Souza said that Goa’s pharmaceutical industry must take up upgradation of primary health centres as welll as discrict hospitals and Goa Medical College and Hospital (GMC). He said that there are several companies whose units are located in the state. “They must take up development of government health facilities through CSR programs,” said D’Souza.

D’Souza also urged industry to keep prices of essential medicines under control for patients. The government will provide the necessary infrastructure for smooth functioning of units, he assured industry.

Siddharth Kuncalienker, chairman, EDC was also one of the guests and in his address, he promised that the EDC would extend a helping hand to units for up gradation of their existing facilities.

Salim Veljee, director, FDA, in his address strongly recommended that CSR activities for health care centres need to be given top priority by industry for centres of health care. He pointed out that the process of simplifying  the Drugs and Cosmetic Act is ongoing and that lot of initiatives have been carried out on that front.

Earlier Suresh Kamath, outgoing president, GPMA, stressed the need of manufacturing units contributing atleast one per cent of their profitability the society.  There are over 70 units operating in Goa of which 40 units are 100% export oriented. The industry does over Rs 10,000 crore business annually which is almost 12 per cent of India’s exports in pharmaceuticals, said Kamath.

GPMA he said conducts various free medical camps across the state and gives scholarships to students of the Pharmacy College on merit and need basis. In addition it also conducts various technical seminars for pharma professionals working in various units in Goa, he said.

K Narendran, CDSO in his speech requested members to submit a copy of application for renewal of GMP to the local office for effective and faster clearance so that COPP ( certificate of pharmaceutical product) can issued by local FDA.

Sanjay Priolkar is the new GPMA president for a term of 2016-2018. Pant, treasurer GPMA proposed the vote of thanks.


http://www.navhindtimes.in/pharma-units-face-water-power-supply-problems-gpma/

Thursday, July 7, 2016

The Indian pharmaceutical industry is growing in the tech pill for pharma sector



Institute watch

*   Institutes offering Pharmaceuticaltechnology are:

* Institute of Chemical Technology (ICT), Mumbai-

* Anna University , College of Engineering, Chennai

* Calcutta Institute of Pharmaceutical Technology, Kolkata

* Jadavpur University, Kolkata

Usha Albuquerque
Every day we hear about a new drug or medicine being developed. Today we have a drug for practically every disease, or are in the process of developing drugs to alleviate all diseases known to man. With the complexities of medicine and the thousands of drugs being developed and dispensed every day doctors and the general public have come to rely quite heavily on the specialised knowledge of pharmacists.

Pharmaceutical Engineering/Technology is a broad field connected to the process of designing, producing, and marketing pharmaceuticals. Pharmaceutical engineers are concerned with the transformation of raw materials into valuable products by chemical, biochemical or physical processes. Basically, this is a field of chemical engineering and pharmaceutical engineers utilise the concept of both biology and biochemistry to design, develop, and manufacture pharmaceutical drugs. They work alongside chemists and pharmacists to research and develop active pharmaceutical ingredients, and then formulate it into the product that a patient takes. Chemical and pharmaceutical engineering overlaps with other branches of engineering, as well as with chemistry and biochemistry. This blend of subject material and emphasis on a broad range of physical and chemical processes makes it a distinct and unique discipline. The other branches of Pharmaceutical Technology include: pharmaceutical formulation, pharmaceutical manufacturing, dispensing pharmacy, physical pharmacy and pharmaceutical jurisprudence.

Getting in
There are only a limited number of institutes that offer an undergraduate degree (BE/BTech/BSc) in pharmaceutical science and technology; so many youngsters enter the field at the moment with a chemical or industrial engineering degree.

The minimum eligibility for undergraduate programmes (BE/BTech/BSc) in pharmaceutical science and technology/ pharmaceutical engineering is Plus II with physics, chemistry, and mathematics as mandatory subjects. For admission to postgraduate programmes (ME/MTech/MSc), you would require a bachelor's degree in the relevant subject from a recognised university. Those interested can continue their studies after MTech in research work in the relevant field.

There are many different skills that a pharmaceutical engineer must possess, including a thorough understanding of the technical aspects of the work and of product development, manufacturing systems, quality control, compliance with regulations and production plants /equipment safety. You also need critical thinking and analytical skills, and an ability to design, maintain and operate highly specialised technology.

Job prospects
With more and more pharma companies taking to R&D there are ample growth opportunities for pharmaceutical engineers. They can work in manufacturing, as drug inspectors, drug analysts, pharmacology experts, production managers, and quality managers in government departments, research institutes and with pharmaceutical companies.

Most private pharmaceutical companies have their own research laboratories and recruit pharmaceutical technologists for carrying out research and development of drugs, and for conducting testing and clinical trials and quality control before the drugs are released in the market. These include companies like Dr. Reddy's Laboratories, Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Novartis India, Astra Zenecca and others. Food and drink companies and cosmetic manufacturing companies also employ pharmaceutical engineers to work in manufacturing, R & D and quality control.

There is also scope with government institutes and organisations involved in research and development of drugs and formulations, regulation of their quality, prices etc. These include institutes such as Central Drug Research Institute (CDRI) Lucknow; National Chemical Laboratory, Pune; Council of Scientific and Industrial Research (CSIR); Indian Institute of Chemical Technology, (IICT) Hyderabad; Central Drug Standards Control Organisation (CDSCO); National Pharma-Co-Vigilance Centre; The Department of Pharmacology, AIIMS, New Delhi; National Institute of Pharmaceutical Education and Research (NIPER); and Indian Medicines Pharmaceutical Corporation limited. (IMPCL).

Pharma engineers can also join Government as Drugs Inspectors in the area of regulatory affairs. This involves the licensing and inspection of medicines and their manufacture to ensure efficacy, safety and quality. Other opportunities for graduates in pharmaceutical sciences include teaching and academics.

The Indian pharmaceutical industry is growing in size and credibility. Not only do we export pharmaceuticals at cheaper prices to more than 200 countries, including USA, Russia, Germany, United Kingdom and Brazil, but India is also the leading supplier of AIDS drugs to the world. There is also a huge investment being made in setting up R & D laboratories for development of new drugs, for testing and contract research, all of which will require qualified pharmaceutical professionals.

So if you have the interest and the skills required for the career, there is scope for tremendous growth, both in the Indian market and globally.

http://www.tribuneindia.com/news/jobs-careers/be-the-tech-pill-for-pharma-sector/261568.html

Sunday, May 1, 2016

Indonesia keen to explore pharma, IT trade ties with India

Panaji: Though bilateral trade between Indonesia and India touched $14.45 billion, the trade figures are far from the true potential that trade opportunities offer for the two Asian countries. Consul general for the Republic of Indonesia Saut Siringoringo, while speaking to TOI, said that bilateral relations especially trade had suffered due to neglect on the part of both the countries.

"We find that India is a big market with very good potential. Last year we touched trade of $14.45 billion. This is very small. India and Indonesia are two of the three biggest countries in population in the region and are two members of G20 and these two countries are major economies in Asia. We have so much potential," Siringoringo said.

Siringoringo, along with the consul for economics Hariyanta Soetarto and director of Indonesian Trade Promotion Centre Walfred Tagor Manihuruk are in Goa to explore trade and investment opportunities. "For the time being we see that the most possible sectors to develop is pharmaceutical, Information Technology, education, manufacturing, biotechnology and fertilizers. "Implementation of ASEAN-India Free trade agreement has contributed a lot to increase trade relations," Soetarto said.

With Indonesia keen to spur investment and trade, a move has been made to revive the Biennial Trade Ministers' Forum. "At the end of May our minister of trade will meet your minister of trade. This forum between the ministers of trade that has been delayed by more than three to four years and there are a lot of things to discuss. The minister of trade will bring business leaders and there will be B2B meetings and government level meetings too," Siringoringo said.

Recommended By Colombia


During this meeting, the two sides hope to ink the comprehensive economic cooperation agreement, a free trade agreement and other economic cooperation deals to boost growth between the two nations.


One of the key hurdles for better trade and tourism relations is the lack of direct flights between the two nations. The two nations have opened discussions to try and resolve the issue and deliberations indicate that direct flights from Mumbai and Delhi to Jakarta could be launched by mid-2016. The Indonesian minister of transport, who is also the official interlocutor between the two nations, has taken the issue on priority.

"I see the sincerity and serious discussions on this. We will help, facilitate such a direct flight from India," Soringoringo said.

Indonesian national carrier Garuda Indonesia has also expressed an interest to begin flights on Indian routes.

http://timesofindia.indiatimes.com/city/goa/Indonesia-keen-to-explore-pharma-IT-trade-ties-with-India/articleshow/52034534.cms

Sunday, March 6, 2016

Parul University Faculty of Pharmacy organizes two-days conference in india

Faculty of Pharmacy of city-based Parul University (PU) organized a two days international conference on 'advances in formulation development: challenges and applications' that concluded on Saturday.

The conference was aimed to enrich the knowledge of budding students, researchers, academicians and industrialist about the recent advances in formulation development with focus on their applications.

The conference highlighted the challenges faced during the development of new drug products.   

Distinguished national and international speakers were invited to deliver talks on various topics of the conference theme.

About 450 delegates from different parts of India participated in the conference and around 100 delegates presented their research work during poster presentation session.

During the scientific sessions, the conference covered different topics like target-based drug discovery and advanced nano-delivery system for herbal medicine, controlled release dosage form: drug release and factors influencing their drug, international regulatory requirements for drug product registrations, challenges in transdermal drug delivery, quorum sensing inhibitors to combat drug resistance and application of IVIVC in evaluation of formulations.

While Dr Sunil Jambhekar, professor of School of Pharmacy, of Florida-based Lake Erie College of Osteopathic Medicine was chief guest at the inaugural function, Dr Pawan Kothari, vice-president operations (API), IPCA was chief guest at the valedictory function.


Baby survives after being given overdose in pharmacy blunder

An infant with a hole in his heart had his life put in danger after a pharmacy misread a prescription and gave him drugs 10 times stronger than they should have been.

His parents now face an anxious wait to see if their son has lasting brain damage and are about to lay a complaint with the Health and Disability Commissioner.

Ben Tuffin has called the ordeal a "nightmare" and is urging parents always to double-check their child's medication.

"I want to get the word out so other families know and take more precautions when it comes to scripts. Pharmacists need to check - when it's done by someone like that you put your trust in them."

On January 8, Tuffin and fiancee Nina Brickland welcomed Sydney Junior Tuffin into the world, but he was born with a hole in his heart.

The neonatal doctor at Middlemore prescribed 0.5ml a day of furosemide, a diuretic to keep the fluid off his lungs while he gained weight and grew strong enough for heart surgery. The parents went to a pharmacy not managed by the hospital to fill the script, then took their new son home. They thought they were doing everything right, administering the medicine once a day through Sydney's nasal tube and even had a home nurse visit daily.

But he kept losing weight.

The parents took him back to the hospital and Tuffin said the doctors and nurses instantly suspected what might be wrong.

Tests confirmed Sydney had very low sodium levels - a symptom of dehydration from an overdose of diuretics. Sydney had been given 5ml a day - 10 times the prescribed dose.

"Because he was on such a high dose, every bit of food or water, it was just sucking all of it out of him," Tuffin told the Herald on Sunday.

The doctor told him if they hadn't brought Sydney in, he would have suffered kidney damage. Because he spent a fortnight severely dehydrated, he could also have suffered brain damage, but they won't be able to tell for a few years.

The Herald on Sunday has seen the doctor's prescription, and the drugs dispensed by the pharmacy, which exposes the error.

Auckland University professor and neonatal paediatrician Jane Harding said furosemide could cause dehydration and kidney damage.

Although brain damage was possible, it was "extremely unlikely", she said.

Tuffin said he was furious at the pharmacy.

"We checked the script and the doctor got it right, it was the pharmacy that screwed it up ... they gave us full strength and they should have known straight away, because it was for a new-born baby.

"They were just careless.

"I wanted to go down to the pharmacy and have it out with the pharmacists but I kept my cool."

Tuffin said as soon as his son got the correct dosage, he started getting better. By the next day, he had gained 50 grams and after a further six days in the Kidz First unit, Sydney was discharged.

"If we actually had the correct dosage at the beginning, our baby would have been nice and strong and ready for surgery."

The pair intend laying a complaint about their ordeal with the Health and Disability Commissioner.

"I want them to be more on to it. If it's a new-born baby that's under six months and they're already sick, they need to be triple or quadruple checking these prescriptions."

The pharmacy involved did not respond to interview requests.

What is furosemide?

A diuretic that causes the kidneys to get rid of unneeded water and salt from the body into the urine.

• Correct dose: 0.5ml a day

• Dose given: 5ml a day

http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11600767

Monday, February 8, 2016

Online pharmacies in India $18 billion market set to grow to $55 billion by 2020, are they even legal?

New Delhi: It’s a $18 billion market set to grow to $55 billion by 2020 and it’s finally beginning to get the kind of attention from investors and entrepreneurs those numbers warrant—despite uncertainty over the legality of the business itself.

The business is online pharmacies, and according to start-up data tracker Tracxn, so far, the sector has attracted $92.6 million funding with over $70 million coming only in 2015.

Almost 31 start-ups were launched last year, with the major chunk of investment announced by Netmeds ($60 million), followed by 1MG ($6 million) and Zigy ($3.2 million).

Investors include IT industry veteran Phaneesh Murthy (in Zigy) and global healthcare fund Orbimed (in Netmeds).

Some of them are no doubt taking heart from the Indian drug controller’s approach. In December, the Drug Controller General of India formed a seven-member panel to look into the issue of online drug sales.

“We are very clear on this issue; we want this technology in the country because our aim is to ensure that patients get quick service and of the right quality. We want to see how the issue can be addressed without compromising on safety. There are chances of abuse of technology as well that we want to plug,” said G.N. Singh, Drug Controller General of India (DCGI).

This is a tricky sector, admits Hemant Bhardwaj, co-founder of Zigy, adding that he and Murthy hired three law firms in 2014 just to ascertain if the business was legal.

“It is largely about the interpretation of law. The Pharma Act had no clarity on electronic copy of a prescription. However, the IT Act says that any digital copy of a document will be valid if there is an original copy which can be presented at the time of verification,” said Bhardwaj, adding that he launched Zigy only after getting a green signal from the law firms.

The company, which runs a marketplace model, doesn’t own a pharma retail licence.

“If you are working as a marketplace, you are working on the licence of one of your vendors. Inventory is not held by the marketplace, it is held by the vendors,” said Bhardwaj.

That’s the same model followed by Netmeds (Netmeds Marketplace Ltd).

“If you look at e-commerce firms such as Flipkart, the bill is generated by WS Retail or other vendors. It is the same philosophy that works here, but in this case, the vendor needs to be an authorized licensed retailer to do so,” said Pradeep Dadha, founder and chief executive officer of Netmeds.

The company has made India Post its logistics partner for delivery.

It works with wholesalers and retailers on a commission basis and sells chronic medicines apart from nutritional products. It sells drugs after receiving a scanned copy of the prescription.

Earlier this month, it also forged partnerships with online doctor booking and consultation sites Lybrate Inc. and Doctor Insta Pvt. Ltd to serve their customers.

Most online pharmacies do not sell Schedule X medicines such as sleeping pills.

Zigy operates across five cities and has tied up with local vendors to comply with the law, which doesn’t allow drugs prescribed in one state to be sold by a pharmacist in another.

With more customers willing to shop online for just about anything, and smartphones facilitating such transactions, the timing is just right for online pharmacies, say entrepreneurs.

“We were waiting for the opportune time. The moment we saw people were buying spinach and okra online, we knew the market was ripe for us,” said Dadha of Netmeds.

And with smartphones, “clicking a picture of the prescription is easy”, said Prashant Tandon, co-founder of 1MG.

Industry experts estimate the market to be generating 3,000-4,000 orders on a daily basis.

The regulator’s positive stance has made companies and investors comfortable with the business models.

“The sector offers great business potential. Online sale of medicines is not a new concept. But in India, till we entered, there were hardly any online pharmacies with serious intent,” said Murthy, former chief executive of iGate Corp.

Much like in e-commerce, discounts are prevalent, although they rarely exceed 20%.

Still, that’s been enough to provoke the strong pharma retail lobby to protest the entry of online pharmacies.

The All India Chemists and Druggists Organization (AICDO) protested in October, accusing online pharmacies of taking away their business by offering deep discounts. The association also claimed that these firms would lead to a deterioration in the quality of medicines as they need to be stocked at specified temperatures.

Online firms, however, have now formed a lobby of their own called the Indian Internet Pharmacy Association (IIPA).

In an attempt to level the playing field, the DCGI issued a fresh circular on 30 December saying that, “the rules do not distinguish between the conventional and over the Internet sale of drugs”.

It, however, added that there will be a “strict vigil” on the online sale of medicines and action would be taken against companies if they are found to be in breach of regulations.

http://www.livemint.com/Companies/EGTOILRRNF0T3J4OfUg9SN/Will-online-pharmacies-work-in-India-and-are-they-even-lega.html

The pill that costs $9,000 in US sells for $70 in Indian Country

And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global price

The Hyderabad-based Bharat Biotech might be the first to come out with a vaccine for the Zika virus if its efficacy can be proved. If it does succeed, this won't be the first time India has come to the rescue of the world. Indeed, the country's generic medicines are a lifeline for millions not only in low and middle-income countries but also in the developed world. India's generic industry hit global headlines in 2001 when Cipla offered a three-drug cocktail for AIDS at less than a dollar a day , a fraction of the price charged by multinationals. Today, apart from several HIVAIDS drugs, the industry is producing affordable, high quality medicines for several diseases including hepatitis B and C, cancers, drug-resistant TB and asthma. This has been credited to India's patent law, often held up as a model one in preventing the abuse of patent monopolies, and in balancing public interest and the growth of the pharmaceutical industry .

Last month, generic manufacturer Natco announced that it would be supplying daclatasvir, a Hepatitis C drug, to 112 developing countries. In 2013, a medicine to treat hepatitis C, sofosbuvir, hit international headlines for its price -$1,000 per pill. Gram for gram, it cost 67 times the price of gold. The sofosbuivir and daclatasvir combination used for the disease costs almost $150,000 per patient for the 12-week regimen in the US. But in India, it is priced at just $700 or a little over Rs 46,500 per patient for the same regimen. And prices are expected to fall further.

Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the US. In countries like Brazil or South Africa, these are a third or a fifth of the US price. The Indian price is often 1100th. (See box)

BALANCING PATIENT AND PATENT

So how does the Indian generic industry manage to do it? The patent law in India is stringent on what is innovative enough to get a patent. Plus, the crucial section 3(d) in the law, much criticized by multinationals, has prevented "evergreening" -the attempt to patent different aspects and improvements of the same drug to extend the period of patent -a lucrative game for the pharmaceutical business.

Indian courts, too, have played a role. In the case of entecavir for hepatitis B and erlotinib for lung cancer, for instance, instead of blindly handing out injunctions or upholding the validity of patents, the courts ruled in favour of public access to a lifesaving drug. This encouraged companies like Cipla, Ranbaxy and Natco to do a `launch at risk', a term that describes a company deciding to challenge a patent by launching a generic version. This forces the patent-holding company to take them to court, thus testing the validity of the patent granted. Patent oppositions filed by patient groups also spurred the rejection of several frivolous patent claims on cancer, hepatitis and HIV medicines, protecting generic competition.

India's patent law also provides for granting of compulsory licences -under which the government can give a licence to a manufacturer other than the patent holder for a royalty fixed by it -for public health reasons. This can be used where drugs are unavailable or unaffordable. The only compulsory licence granted was in 2012 when the patent office allowed the Indian generic company Natco to market sorafenib, a drug patented by Bayer to treat kidney and liver cancer.This move, upheld by the Supreme Court in December 2014 helped bring down the price by 97%, unimaginable through a price negotiation with the company .

"How long will this continue? We are already feeling the adverse impact of monopoly and limited access to important drugs. If India cannot manufacture newer drugs, how can we be the pharmacy of the world?" asked Dr Yusuf Hamied, of Cipla.

http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/The-pill-that-costs-9000-in-US-sells-for-70-in-India/articleshow/50887471.cms

Wednesday, August 26, 2015

Etailers like Flipkart, Amazon as Drugs Act to be allow online sales


HYDERABAD: The government may consider changes to the Drugs and Cosmetics Act to permit online sale of medicines following representations made by organised retail chains such as Apollo Pharmacy, Medplus and Hetero. This follows a crackdown by drug regulators against the sale of medicines a few weeks ago through websites.

The issue is being examined by a sub-committee appointed by the Drugs Controller General of India (DCGI) and headed by Maharashtra Food and Drug Administration (FDA) commissioner Harshadeep Kamble. It's likely to suggest that online sales be allowed with adequate safeguards pertaining to prescriptions and pharmacy licences, said a top official aware of this. Kamble didn't respond to queries from ET.

The Maharashtra FDA had in May filed cases against online retailers like Snapdeal for selling prescription drugs without valid prescriptions or licences.

"The committee is yet to firm up its recommendations but drug controllers of many states have submitted their proposals to the government," a member of the DCGI panel told ET. "Majority members of the sub-committee are in favour of considering the pleas of trade bodies, pharmacy chains and e-tailers to allow online sale of medicines with adequate safeguards taking into account the global practices."

The recommendations of various state drug controllers and the subcommittee, if approved by the government, could open up a large business opportunity to online players such as Snapdeal, Amazon India and Flipkart, apart from pharmacy retailers.

The domestic medicine market is growing at around 10-15% a year and is estimated at around .`90,000 crore. Allowing online sales would also help organized retail pharmacy chains that are setting up virtual account for nearly 5% of the market and are growing in double digits.

Akun Sabharwal, director of Telangana's Drugs Control Administration, said he has recommended to the government that the Drugs and Cosmetics Act be amended to enable the online sale of medicines.

"Online pharmacy, once legal sanction is given, can be operated by anyone who will meet the standards desired by the revised Drug and Cosmetics Act," he said. Sabharwal, a doctor turned administrator who has studied the US model of dispensing medicines online, said, "There should be an equal opportunity for all people to be part of the process if they follow the statute."

However, brick and mortar pharmacy players fear a serious threat to their existence if online sales of medicines is permitted, said JS Shinde, president of the All India Organization of Chemists and Druggists, which represents over 7.5 lakh chemists across the country. Well-funded online retailers, both domestic and global, could easily manage to obtain licences to adhere to a tweaked Drugs and Cosmetics Act, he said, putting at risk small, neighbourhood stores.

Growing real estate costs in urban areas could lead to drug retailers having to rationalise their brick and mortar models and shift to online sales by ensuring delivery of drugs by pharmacists after verifying doctor's prescription, Sabharwal said. This suggests that the local store could still play a role in last-mile delivery in an online transaction.

Medplus, one of the largest organised pharmacy chains with 1,300 stores across several cities and a turnover of Rs 1,800 crore, moved online recently in the wake of rising demand. "We have been witnessing double-digit growth in online sales," said chairman Madhukar Gangadi. "While online sales will lead to rationalising the brick and mortar shops, it helps in reducing overheads and improving margins faster."

http://articles.economictimes.indiatimes.com/2015-08-19/news/65592201_1_online-sales-apollo-pharmacy-drugs-and-cosmetics-act

Thursday, July 30, 2015

Sainsbury’s has sold its 281-store pharmacy business to Celesio

Sainsbury’s has sold its 281-store pharmacy business to Celesio, the owner of the Lloyds Pharmacy chain, for £125m.

Under the deal, Lloyds will rent out and run Sainsbury’s 277 in-store pharmacies and take over four located in hospitals. Up to 2,500 Sainsbury’s pharmacy staff will transfer to Lloyds.

Mike Coupe, chief executive of Sainsbury’s, said: “Working together with a specialist operator like Lloyds Pharmacy will enable us to grow and extend our pharmacy services to customers, whilst realising value for shareholders today from the pharmacy business we have grown organically over the last 20 years.”

Analysts said the cash from the deal would further strengthen Sainsbury’s balance sheet after the retailer raised £500m through bond issues last week. It told analysts that roughly half the bond funds would be used to pay down its pension deficit while the other half would be used to “get on the front foot with corporate plans”.

Bruno Monteyne, an analyst at Bernstein Research, said: “These funds are not immediately necessary. The market was not waiting for this, but it is reassuring if somewhat unexpected.”

Without major pressure from investors for cash-raising measures, Sainsbury’s sudden flurry of fundraising activity is likely to heighten speculation that the retailer is looking to buy out a chain or batch of stores to help expand either its convenience store brand, Sainsbury’s Local, or its nascent discounter joint venture, Netto.

Sainsbury’s plans to reach a total of 15 Netto stores this year, including the buy-out of three Co-op stores in Leeds, Hull and Doncaster, which is currently being reviewed by the competition regulator.

http://www.theguardian.com/business/2015/jul/29/sainsburys-sells-pharmacy-business-celesio-125m

Sunday, July 12, 2015

French startup 1001Pharmacies just raised $8.9 million (€8 million) from Newfund, CM-CIC Capital

French startup 1001Pharmacies just raised $8.9 million (€8 million) from Newfund, CM-CIC Capital Privé, and business angels, such as Xaviel Niel, Pierre Kosciusko-Morizet and Olivier Mathiot. As the name suggests, 1001Pharmacies is an online pharmacy.

The company first let you order your prescription goods from their website. In order to avoid legal issues, 1001Pharmacies partnered with hundreds of brick-and-mortar pharmacies and acted as the middleman, handling deliveries, payments and listings.

Last August, the company had to stop its prescription delivery service as a French court ruled that delivering prescription goods was illegal. That’s why the company refocused on non-prescription goods, from toothpaste to vitamin C effervescent powder. As long as you don’t need a prescription, you can find it on 1001Pharmacies.

And it looks like this strategy is working as the company managed to raise €8 million despite last year’s ban. 1001Pharmacies still hopes that it will be able to sell prescription goods in the near future.

As this is a highly regulated industry, 1001Pharmacies faces challenges that it wouldn’t face in other countries. But if the startup can crack the code in France, it will create a significant barrier to entry for other potential competitors.

Finally, the marketplace approach is interesting. Not having to manage a huge inventory and many of the less-scalable tasks of an e-commerce startup is a great asset. Clients can even order stuff online and then grab them at their local pharmacy. It’s a great way to know for sure that the pharmacy will have what you are looking.

Pharmacies get a new sales channel, 1001Pharmacies takes a cut, and clients have another way to buy non-prescription goods. As these goods have very high margins, 1001Pharmacies may have found a lucrative business.

techcrunch.com/2015/07/09/1001pharmacies-grabs-8-9-million-to-bring-your-pharmacy-to-the-web/

Saturday, June 20, 2015

Target selling clinics, pharmacies to CVS Health for $1.9 billion

Target’s pharmacies, clinics, will be rebranded as CVS/pharmacy and MinuteClinic locations.

Target’s TGT 0.19% pharmacies will soon all become CVS locations.

The discount retailer and CVS Health CVS 0.39% announced a deal worth $1.9 billion Monday under which Target will sell its 1,660 pharmacies and 80 clinics, which will be rebranded as CVS/pharmacy and MinuteClinic locations. These will be operated as “stores within a store.”

For Target, the deal gives it cash injection a few months after it took a $5 billion write down on its aborted Canadian business, and the deal lets it concentrate on its e-commerce and core retail businesses. It will also allow it to improve its health and wellness offerings, a key prong in Target CEO Brian Cornell’s strategy for rejuvenating its business.

As for CVS Health, the deal allows it to expand its retail footprint by hundreds of locations as it competes with Walgreens WBA 0.82% , currently the largest U.S. drugstore operator. In particular, it will get a stronger presence in key markets such as Seattle, Denver and Salt Lake City. CVS/pharmacy currently has 7,800 drugstores (Walgreens has more than 8,000.)

Read about Target in the new Fortune 500

CVS Health said it will open as many as 20 new clinics in Target stores within three years of the close of the deal, part of its plan to operate 1,500 MinuteClinics by 2017. Target plans to build out five to 10 small, flexible format stores within two years under the TargetExpress name. Those will include a CVS/pharmacy.

“By partnering with CVS Health, we will offer our guests industry leading health care services, and at the same time, sharpen our focus on elevating the way we deliver wellness products and experiences to our guests,” Brian Cornell, Target Chairman and CEO, said in a statement.

http://fortune.com/2015/06/15/target-cvshealth/

Monday, April 20, 2015

Ali Health to become Alibaba's pharmacy platform

After a 15-day share trade suspension, Hong Kong-listed Ali Health Information Technology announced on April 15 that it will acquire online pharmacy assets from its parent company Alibaba Group Holding, the largest e-commerce operator in China.

Ali Health will issue new shares and convertible bonds to Alibaba under the terms of the deal, which is estimated at about HK$19.4 billion (US$2.5 billion).

With the acquisition, Alibaba's stake in Ali Health will increase from 38% to 53%, Shanghai's China Business News reported. Ali Health will also sell convertible bonds to Alibaba, which will further increase the parent company's share to 54.6% if they are exchanged for common shares, the paper said.

As a result, the report said, Ali Health is expected to become the major growth driver of Alibaba's online pharmacy business.

Following the announcement of the acquisition, shares of Ali Health rose about 77% to HK$12 (US$1.54) in early trading on the Hong Kong Stock Exchange April 15, and the stock ended up 80.83% at HK$12.26 (US$1.57) at close of trade.

The paper said the online pharmacy assets Ali Health will acquire are held under Alibaba's TMall's pharmacy marketplace and include 186 online-licensed pharmacies that sell non-prescription medicines, medical equipment, contact lenses and health food supplements.

In the period March 2014 to March 2015, TMall Pharmacy posted revenues of 4.7 billion yuan (US$758 million), which helped to boost the value of the operations in the acquisition deal, the paper said.

In addition, the pharmacy launched an express delivery service in, Beijing, Shanghai and Hangzhou in February, allowing consumers to obtain medicine from their nearest bricks-and-mortar drug store within three hours of placing an online order. The service has boosted the value of the pharmacy's operations, the report said.

The 186 online pharmacies that will be transferred in the acquisition deal have Type C certification under China's internet and drug transaction services qualification system, the report said. This will help Ali Health set up a comprehensive distribution network and enhance its efforts to build a cloud computing technology-based medical services platform, according to the report.

Alibaba chief operating officer Zhang Yong told the paper that his group wants to take advantage of cloud computing technology to improve medical services in China.

According to the report, Alibaba is aiming to set up a system, using cloud computing technology that will allow interaction between patients and doctors. Patients will be able to seek advice and doctors will be able to issue prescriptions that can be filled via the group's medical services platform, the report said.

There is much room for growth in China's online medical services if the country lifts its tight controls on that line of business, the paper said.

In the United States, health costs account for about 15% of the country's gross domestic product, but in China with a population of 1.3 billion, the ratio is between 5% and 6%, the report said.

Apart from Alibaba, other two online business giants–Baidu and Tencent–are eyeing the huge growth potential of China's online pharmacy business, the report said.

http://www.wantchinatimes.com/news-subclass-cnt.aspx?id=20150419000011&cid=1102